Treatment of malignant ascites in patients with advanced cancer: Peritoneovenous shunt versus paracentesis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 22, Issue 12, 2007, Pages 2161-2166

  Seike, Masahiro ^a   Maetani, Iruru ^a   Sakai, Yoshihiro ^a  

^a TOHO UNIVERSITY OHASHI MEDICAL CENTER   (Japan)

Author keywords

Malignant ascites; Paracentesis; Peritoneovenous shunt; Quality of life; Refractory ascites

Indexed keywords

CREATININE; NITROGEN; UREA;

ADULT; ADVANCED CANCER; AGED; ARTICLE; ASCITES TUMOR; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HEMATOCRIT; HOSPITAL DISCHARGE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PARACENTESIS; PERFORMANCE; PERITONEUM VEIN SHUNT; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; UREA NITROGEN BLOOD LEVEL;

EID: 36348979798     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04793.x     Document Type: Article

References (20)

1. Parsons SL, Watson SA, Steele RJ. Malignant ascites. Br. J. Surg. 1996 83 : 6 14.
2. Smith EM, Jayson GC. The current and future management of malignant ascites. Clin. Oncol. (R. Coll. Radiol.) 2003 15 : 59 72.
3. Oris F, Grasso RF, Bonomo G, Monti C, Marinucci I, Bellomi M. Percutaneous peritoneovenous shunt positioning technique and preliminary results. Eur. Radiol. 2002 12 : 1188 92.
4. Garrison RN, Kaelin LD, Galloway RH, Heuser LS. Malignant ascites. Clinical and experimental observations. Ann. Surg. 1986 203 : 644 51.
5. Senger DR, Van de Water L, Brown LF et al. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev. 1993 12 : 303 24.
6. Smith AN. Peritoneocaval shunt with a Holter valve in the treatment of ascites. Lancet 1962 31 : 671 2.
7. Hyde GL, Dillon M, Bivins BA. Peritoneal venous shunting for ascites: a 15-year perspective. Am. Surg. 1982 48 : 123 7.
8. Leveen HH, Christoudias G, Ip M, Luft R, Falk G, Grosberg S. Peritoneo-venous shunting for ascites. Ann. Surg. 1974 180 : 580 91.
9. Lund RH, Newkirk JB. Peritoneo-venous shunting system for surgical management of ascites. Contemp. Surg. 1979 14 : 31 8.
10. Zanon C, Grosso M, Apra F et al. Palliative treatment of malignant refractory ascites by positioning of Denver peritoneovenous shunt. Tumori 2002 88 : 123 7.
11. Bieligk SC, Calvo BF, Coit DG. Peritoneovenous shunting for nongynecologic malignant ascites. Cancer 2001 91 : 1247 55.
12. Adam RA, Adam YG. Malignant ascites: past, present, and future. J. Am. Coll. Surg. 2004 198 : 999 1011.
13. Gough IR, Balderson GA. Malignant ascites. A comparison of peritoneovenous shunting and nonoperative management. Cancer 1993 71 : 2377 82.
14. Fildes J, Narvaez GP, Baig KA, Pai N, Gerst PH. Pulmonary tumor embolization after peritoneovenous shunting for malignant ascites. Cancer 1988 61 : 1973 6.
15. Downing R, Black J, Windsor CW. Palliation of malignant ascites by the Denver peritoneovenous shunt. Ann. R. Coll. Surg. Engl. 1984 66 : 340 3.
16. Parsons SL, Lang MW, Steele RJ. Malignant ascites: a 2-year review from a teaching hospital. Eur. J. Surg. Oncol. 1996 22 : 237 9.
17. Smith DA, Weaver DW, Bouwman DL. Peritoneovenous shunt (PVS) for malignant ascites. An analysis of outcome. Am. Surg. 1989 55 : 445 9.
18. Faught W, Kirkpatrick JR, Krepart GV, Heywood MS, Lotocki RJ. Perioneovenous shunt for palliation of gynecologic malignant ascites. J. Am. Coll. Surg. 1995 180 : 472 4.
19. Hussain FF, Meer ZF, Lopez AJ. Perioneovenous shunt insertion for intractable ascites: a district general hospital experience. Cardiovasc. Intervent. Radiol. 2004 27 : 325 8.
20. Lund RH, Moritz MW. Complication of Denver peritoneovenous shunting. Arch. Surg. 1982 117 : 924 8.